Glenn H. Nussdorf

Board Member · Organogenesis Holdings Inc.

Rank #4,208 SEC EDGAR (United States) ↗ Files from United States

Details

Member of the boardPharmaceuticals & BiotechnologyORGOSEC CIK 0001244191

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$20.1M
1-day change
▲ 4.27%
Positions on file
1
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$20.1M – $71.7M2026-09-04

Insider activity Nov 12, 2024 – Dec 16, 2025

Glenn H. Nussdorf is recorded in filings to the U.S. SEC via EDGAR as member of the board, and reported 25 transactions between Nov 12, 2024 and Dec 16, 2025. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
$1.10M
2 purchases on file priced rows only
Open-market sales (code S)
$2.70M
6 sales on file priced rows only
All reported transactions
25
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 18 most recent rows are grouped into 13 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Organogenesis Holdings Inc. ORGO S Open-market sale 200,000 shares $1.03M at $5.14 SEC filing ↗
  2. Organogenesis Holdings Inc. ORGO S Open-market sale 187,957 shares $994.3K at $5.29 SEC filing ↗
  3. Organogenesis Holdings Inc. ORGO S Open-market sale 12,043 shares $63.8K at $5.30 SEC filing ↗
  4. Organogenesis Holdings Inc. ORGO S Open-market sale 100,000 shares $534.0K at $5.34 SEC filing ↗
  5. Organogenesis Holdings Inc. ORGO S Open-market sale 18,620 shares $66.3K at $3.56 SEC filing ↗
  6. Organogenesis Holdings Inc. ORGO S Open-market sale 4,156 shares $14.5K at $3.50 SEC filing ↗
  7. Organogenesis Holdings Inc. ORGO P Open-market purchase 107,494 shares $321.4K at $2.99 SEC filing ↗
  8. Organogenesis Holdings Inc. ORGO P Open-market purchase 251,001 shares $775.6K at $3.09 SEC filing ↗
  9. Organogenesis Holdings Inc. ORGO G Bona fide gift × 2not a buy/sell decisionreported at zero 12,803,890 shares $0
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    6,401,945 $0.00reported at zero $0 SEC filing ↗
    6,401,945 $0.00reported at zero $0 SEC filing ↗
  10. Organogenesis Holdings Inc. ORGO G Bona fide gift × 2not a buy/sell decisionreported at zero 3,421,104 shares $0
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    1,710,552 $0.00reported at zero $0 SEC filing ↗
    1,710,552 $0.00reported at zero $0 SEC filing ↗
  11. Organogenesis Holdings Inc. ORGO D Disposition to the issuernot a buy/sell decision 500,000 shares $2.03M at $4.06 SEC filing ↗
  12. Organogenesis Holdings Inc. ORGO D Disposition to the issuer × 3not a buy/sell decision 6,606,731 shares $20.88M
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    3,761,909 $3.16 $11.89M SEC filing ↗
    294,000 $3.16 $929.0K SEC filing ↗
    2,550,822 $3.16 $8.06M SEC filing ↗
  13. Organogenesis Holdings Inc. ORGO J Other acquisition or disposition × 2not a buy/sell decision 815,000 shares $2.58M
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    590,332 $3.16 $1.87M SEC filing ↗
    224,668 $3.16 $710.0K SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
Organogenesis Holdings Inc. ORGO Class A Common Stock (indirect) 11,748,560 $1.71 $20.1M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Glenn H. Nussdorf reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.